We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+9.94%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$14.2B
AUM Growth
+$958M
Cap. Flow
-$51.9M
Cap. Flow %
-0.37%
Top 10 Hldgs %
18.13%
Holding
1,975
New
105
Increased
818
Reduced
914
Closed
106

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$57.7M
2
LIN icon
Linde
LIN
+$51.8M
3
MGPI icon
MGP Ingredients
MGPI
+$14.5M
4
CROX icon
Crocs
CROX
+$7.84M
5
UNH icon
UnitedHealth
UNH
+$6.55M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$28.5M
2
PXD
Pioneer Natural Resource Co.
PXD
+$17.6M
3
MSFT icon
Microsoft
MSFT
+$15.9M
4
NVDA icon
NVIDIA
NVDA
+$15.5M
5
MRK icon
Merck
MRK
+$13.9M

Sector Composition

Rank Sector Weight
1 Technology 25.07%
2 Healthcare 9.37%
3 Consumer Discretionary 8.61%
4 Financials 8.24%
5 Industrials 7.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BCRX icon
1851
BioCryst Pharmaceuticals
BCRX
$2.4B
$80.4K ﹤0.01%
15,821
-220
-1% -$1.24K
FIGS icon
1852
FIGS
FIGS
$2.38B
$79.8K ﹤0.01%
16,024
– –
LUMN icon
1853
Lumen
LUMN
$6.44B
$79K ﹤0.01%
50,659
-42,978
-46% -$67.2K
GNT
1854
GAMCO Natural Resources, Gold & Income Trust
GNT
$144M
$74.7K ﹤0.01%
14,329
-13,312
-48% -$66.7K
LILAK icon
1855
Liberty Latin America Class C
LILAK
$1.64B
$70.7K ﹤0.01%
+11,121
New +$68.8K
IAF
1856
abrdn Australia Equity Fund
IAF
$127M
$54.4K ﹤0.01%
4,256
-3,987
-48% -$50.1K
ABCL icon
1857
AbCellera Biologics
ABCL
$2.12B
$52.3K ﹤0.01%
11,544
-194
-2% -$990
SSP icon
1858
E.W. Scripps
SSP
$304M
$52.2K ﹤0.01%
13,286
-3,081
-19% -$18.4K
NIU
1859
Niu Technologies
NIU
$193M
$46.8K ﹤0.01%
27,880
-819
-3% -$1.5K
AMLX icon
1860
Amylyx Pharmaceuticals
AMLX
$2.54B
$46.4K ﹤0.01%
16,338
+1,392
+9% +$18.2K
OPEN icon
1861
Opendoor
OPEN
$3.38B
$42K ﹤0.01%
14,330
+375
+3% +$1.17K
LAZR
1862
DELISTED
Luminar Technologies
LAZR
$41.6K ﹤0.01%
1,408
-511
-27% -$18.6K
DNA.WS
1863
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$36K ﹤0.01%
399,600
– –
SABR icon
1864
Sabre
SABR
$818M
$29.7K ﹤0.01%
12,268
-2,398
-16% -$8.05K
NKLA
1865
DELISTED
Nikola Corporation Common Stock
NKLA
$11.6K ﹤0.01%
372
– –
AKBA icon
1866
Akebia Therapeutics
AKBA
$252M
$1.9K ﹤0.01%
+1,039
New +$1.66K
ABR icon
1867
Arbor Realty Trust
ABR
$998M
– –
-21,712
Closed -$330K
AI icon
1868
C3.ai
AI
$1.59B
– –
-8,514
Closed -$244K
ALGT icon
1869
Allegiant Air
ALGT
$2.57B
– –
-2,640
Closed -$218K
AMCX icon
1870
AMC Global Media
AMCX
$489M
– –
-12,006
Closed -$226K
AMN icon
1871
AMN Healthcare
AMN
$1.4B
– –
-4,751
Closed -$356K
AMTX icon
1872
Aemetis
AMTX
$121M
– –
-15,621
Closed -$81.9K
AQN icon
1873
Algonquin Power & Utilities
AQN
$4.42B
– –
-53,918
Closed -$341K
BAK icon
1874
Braskem
BAK
$913M
– –
-19,791
Closed -$175K
BANC icon
1875
Banc of California
BANC
$2.97B
– –
-71,475
Closed -$960K
73 74
75
76 77

Similar funds

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
AAMU
APG Asset Management US New York $13B AUM 5.3% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return
ACA
Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return
ZIG
Zurich Insurance Group Zurich, Switzerland $12.7B AUM 53.57% 1-Year Est. Return

Guggenheim Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Guggenheim Capital held 1,975 positions worth $14.2B, up 7.2% from $13.2B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Guggenheim Capital's Q1 2024 filing shows 105 new, 818 increased, 914 reduced and 106 closed positions. Its largest new stake was MGP Ingredients: 167,669 shares worth $14.4M. The largest sale was Broadcom, an estimated $28.5M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Guggenheim Capital's largest Q1 2024 buy was MGP Ingredients: 167,669 shares worth $14.4M.
  • Guggenheim Capital added most to State Street SPDR S&P 500 ETF Trust in Q1 2024, an estimated $57.7M increase.
  • Guggenheim Capital's biggest Q1 2024 reduction was Broadcom, cutting an estimated $28.5M.
  • Guggenheim Capital fully exited Splunk Inc in Q1 2024, selling an estimated $9.62M.
  • Guggenheim Capital's ten largest holdings make up 18% of its $14.2B portfolio in Q1 2024.
  • Guggenheim Capital opened 105 new positions and closed 106 in Q1 2024.
  • Guggenheim Capital's portfolio value rose 7.2% quarter-over-quarter to $14.2B.

Based on Guggenheim Capital's 13F filing for Q1 2024, filed 14 May 2024.